Hackers Have Boston Scientific "Skipping a Beat" as a Cyberattack Freezes $BSX Shipments
It’s Wednesday my dudes, and the hackers have officially moved onto the pacemakers. Boston Scientific, the $72 billion company behind the stents and heart implants stocked in hospital supply rooms across America, told the SEC on Wednesday that a cyberattack is quite literally… rawdogging its information systems to the point it can’t process or ship a single order.
The company says it spotted the intruders Tuesday, hit the incident response button, and called in third-party cybersecurity muscle to contain the damage. As for when the lights come back on, the filing offers only that "the timeline for a full restoration is not yet known" (read: we have no f*cking idea). Shares tanked 5.8% in premarket trading. Not great, Bob.
You might recall this is a company that did not need a new problem. The stock has already been cut nearly in half this year, courtesy of a first-quarter profit outlook that came in softer than hospital Jell-O and a fresh guidance cut last month. The villain in that one was Watchman, Boston Scientific's flagship heart implant, which is selling slower because doctors started bundling the procedure into other heart work during a single visit instead of booking dedicated Watchman appointments. Fewer solo bookings, fewer implants, and full-year earnings guidance dropped to $3.28 to $3.32 a share while sales growth got trimmed to 5% to 6%. Translation: The hackers picked a company that was already missionary.
For more context, Piper Sandler got management on the phone Wednesday morning and came away thinking Boston Scientific could be back to shipping everything in under three weeks. That sounds manageable until you remember hospitals order this stuff because a human being is scheduled to have it installed. Woof.
What makes this even more of a clusterf*ck is that earlier this month, Knife Catcher (read: CEO Mike Mahoney), backed up the brinks truck and bought $10 million of his own stock at about $48 a share. Three weeks ago that trade read as conviction from the guy with the best information in the building. This morning it reads like a man who paid eight figures for a front-row seat to get taken behind the barn (and not in a good way).
Of course, the financial damage is still uncounted… the company admits it can't yet say whether the hit is "material," and after two guidance cuts this year, the third press release basically writes itself. Until the systems come back, the pacemaker people can do everything except the one part that pays the bills. Nobody watched the Watchman. Until next time, friends…

At the time of publishing, Stocks.News does not hold positions in companies mentioned in the article.